Condition: Aortic Stenosis · Sponsor: EnCompass Technologies, Inc.
The goal of this clinical trial is to learn about the safety and performance of the F2 device for cerebral embolic protection in participants with symptomatic aortic stenosis underdoing a Transcatheter Aortic Valve replacement procedure. Participants will complete several neurocognitive assessments and an MRI procedure.
This description comes directly from the study's public registry record.
Kathleen Calderon · 307-250-2726 · kcalderon@encompassf2.com
Francis Duhay, MD · 949-285-8170 · fduhay@encompassf2.com
Always discuss trial participation with your own doctor first.
| Healthycore | Tbilisi, Georgia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05866640